CoChat

Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration

Oliver-Fernandez, Alejandro, Bakal, Jeff, Segal, Shaun, Shah, Gaurav K., Dugar, Ashish, Sharma, Sanjay · 2005 · Canadian Journal of Ophthalmology

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Purpose To determine whether the time elapsed from initial (referral) diagnosis of neovascular (wet) age-related macular degeneration (AMD) to assessment and treatment by a retinal specialist is associated with visual deterioration in the intervening period. Methods A prospective pilot study of 38 consecutive AMD patients who presented with newly diagnosed subfoveal choroidal neovascularization was conducted in a tertiary care retinal practice. All eligible subjects underwent clinical examination and digital fluorescein angiography at the time of assessment by a retinal specialist. Correlations were performed to assess the association between continuous independent variables and any visual deterioration since initial diagnosis. Multivariate linear regression models with stepwise techniques were used to evaluate any association between visual progression and time elapsed, while controlling for potential clinical covariates. Results Of the 38 patients, 32 (84%) met the inclusion and exclusion criteria; no differences in important variables were noted between those included and those excluded. The median time between initial diagnosis and referral assessment and treatment was 28 days (interquartile range=36.5 days); some degree of visual loss developed in 14 (44%) of the subjects. The elapsed time was correlated with progression of visual loss (r=0.50, p=0.003). Multivariate linear regression demonstrated that only time elapsed and lesion type based on fluorescein angiography we…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0008-4182(05)80074-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 1

  1. 2004, NCQA adds four new measures to HEDIS 2005, Qual Lett Healthc Lead, 16, 12

Cited by

See all 50

Metadata

Authors
Oliver-Fernandez, A., Bakal, J., Segal, S., Shah, G. K., Dugar, A., & Sharma, S.
Affiliations
  • Queen's University (CA)
  • Washington University in St. Louis (US)
  • Pfizer (United States) (US)
Corresponding author
Sharma, Sanjay
Venue
Canadian Journal of Ophthalmology
Publisher
Elsevier BV
Published
2005-06
Volume
40
Issue
3
Pages
313-319
ISSN
0008-4182 (ISSN-L)
OpenAlex
W1989515430
Cited by
50
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 2
FWCI
1.22
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Canadian Journal of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
neovascular age-related macular degeneration, choroidal neovascularization, treatment delay, time to treatment, fluorescein angiography, lesion type, subfoveal neovascularization
MeSH terms
Aged, Aged, 80 and over, Female, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Macular Degeneration, Male, Pilot Projects, Prognosis, Prospective Studies, Risk Factors, Time Factors, Vision Disorders, Disease Progression, Choroidal Neovascularization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration. https://app.cochat.ai/papers/10.1016/s0008-4182(05)80074-2
The paper
Oliver-Fernandez, A., Bakal, J., Segal, S., Shah, G. K., Dugar, A., & Sharma, S. (2005). Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration. Canadian Journal of Ophthalmology. https://doi.org/10.1016/s0008-4182(05)80074-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.